Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The BOD

But our BOD, or some members, were the ones that agreed with the master, and commericalization agreements that gave far too much power to TPL. Which by the way, at the time, was the only enity with no ownership of the MMP

At the time of the agreement, hadn't TPL/Moore already signed Intel?

Before AMD is used as a counter, check how much PTSC received from TPL/Moore on signing the agreement as the portion of Intel's fee.

Look at what else was also resolved with the agreement. To simply say TPL was given too much power without considering all the prevailing facts is simply denial of the circumstances.

.

.

.

Be well

Share
New Message
Please login to post a reply